Close Menu

NEW YORK – Liquid biopsy firm Biocept on Monday priced a previously announced underwritten public offering of 24,600,000 shares of its common stock paired with warrants to purchase up to the same number of shares. 

Gross proceeds from the offering are expected to be about $10 million, which it will use to support ongoing operations and expansion of its business.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg Law writes that the Genetic Information Nondiscrimination Act may work better as a privacy, rather than anti-discrimination, law.

TechCrunch reports that Linda Avey has a new personal genomics startup that's focusing on India.

A new report finds that though the US has increased its activity in science and engineering, its global share of that activity has fallen in some areas, according to Inside Higher Ed.

In Nature this week: genomic analysis of rapeseed, universal target enrichment method for metagenomic sequencing, and more.